Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.

Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN.

Ann Surg Oncol. 2013 Aug;20(8):2493-500. doi: 10.1245/s10434-012-2864-7. Epub 2013 Feb 3.

2.

Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.

Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D, Motta M, Ravarino N, Risio M, Curley SA, Abdalla EK, Capussotti L, Vauthey JN.

Ann Surg Oncol. 2010 Nov;17(11):2870-6. doi: 10.1245/s10434-010-1166-1. Epub 2010 Jun 22.

PMID:
20567921
3.

What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?

Narita M, Oussoultzoglou E, Fuchshuber P, Pessaux P, Chenard MP, Rosso E, Nobili C, Jaeck D, Bachellier P.

Ann Surg Oncol. 2012 Aug;19(8):2526-38. doi: 10.1245/s10434-012-2274-x. Epub 2012 Mar 7.

PMID:
22395987
4.

Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study.

Young AL, Wilson D, Ward J, Biglands J, Guthrie JA, Prasad KR, Toogood GJ, Robinson PJ, Lodge JP.

HPB (Oxford). 2012 Mar;14(3):194-200. doi: 10.1111/j.1477-2574.2011.00426.x. Epub 2012 Jan 16.

5.

Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.

Kremer M, Manzini G, Hristov B, Polychronidis G, Mokry T, Sommer CM, Mehrabi A, Weitz J, Büchler MW, Schemmer P.

J Am Coll Surg. 2015 Sep;221(3):717-728.e1. doi: 10.1016/j.jamcollsurg.2015.05.017. Epub 2015 Jun 15.

PMID:
26232303
6.

Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.

Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J.

Ann Surg Oncol. 2009 Jun;16(6):1553-9. doi: 10.1245/s10434-009-0447-z. Epub 2009 Apr 11.

PMID:
19363584
7.

Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.

Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN.

J Am Coll Surg. 2013 Feb;216(2):201-9. doi: 10.1016/j.jamcollsurg.2012.10.018. Epub 2012 Dec 7.

8.

Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.

Komori H, Beppu T, Baba Y, Horino K, Imsung C, Masuda T, Hayashi H, Okabe H, Ootao R, Watanabe M, Takamori H, Iyama K, Baba H.

Int J Clin Oncol. 2010 Jun;15(3):263-70. doi: 10.1007/s10147-010-0046-9. Epub 2010 Mar 19.

PMID:
20238233
9.

Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases.

Yamashita S, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN.

J Hepatol. 2017 Jul;67(1):56-64. doi: 10.1016/j.jhep.2017.01.031. Epub 2017 Feb 10.

PMID:
28192187
10.

Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.

Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN.

J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):215-25.

PMID:
15713922
11.

Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections.

Martel G, Cieslak KP, Huang R, van Lienden KP, Wiggers JK, Belblidia A, Dagenais M, Lapointe R, van Gulik TM, Vandenbroucke-Menu F.

HPB (Oxford). 2015 Dec;17(12):1051-7. doi: 10.1111/hpb.12480. Epub 2015 Sep 16.

12.

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity.

Tanaka K, Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Endo I, Ichikawa Y, Taguri M, Tanabe M.

Eur J Surg Oncol. 2015 Apr;41(4):506-12. doi: 10.1016/j.ejso.2015.01.031. Epub 2015 Feb 10.

PMID:
25704556
13.

Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution.

Okabe H, Beppu T, Chikamoto A, Hayashi H, Yoshida M, Masuda T, Imai K, Mima K, Nakagawa S, Kuroki H, Nitta H, Ishiko T, Hashimoto D, Yamashita Y, Baba H.

Int J Clin Oncol. 2014 Aug;19(4):614-21. doi: 10.1007/s10147-013-0591-0. Epub 2013 Jul 17.

PMID:
23860603
14.

Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases.

Makowiec F, Möhrle S, Neeff H, Drognitz O, Illerhaus G, Opitz OG, Hopt UT, zur Hausen A.

J Gastrointest Surg. 2011 Jan;15(1):153-64. doi: 10.1007/s11605-010-1368-7.

PMID:
21061183
15.

Comparison of two methods of future liver remnant volume measurement.

Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Wei SH, Vauthey JN.

J Gastrointest Surg. 2008 Jan;12(1):123-8. Epub 2007 Oct 9.

PMID:
17924174
16.

Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases.

Simoneau E, Alanazi R, Alshenaifi J, Molla N, Aljiffry M, Medkhali A, Boucher LM, Asselah J, Metrakos P, Hassanain M.

J Surg Oncol. 2016 Mar;113(4):449-55. doi: 10.1002/jso.24139. Epub 2016 Mar 9.

PMID:
26955907
17.

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization.

Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN.

Arch Surg. 2002 Jun;137(6):675-80; discussion 680-1.

PMID:
12049538
18.

Hypophosphataemia after major hepatectomy and the risk of post-operative hepatic insufficiency and mortality: an analysis of 719 patients.

Squires MH 3rd, Dann GC, Lad NL, Fisher SB, Martin BM, Kooby DA, Sarmiento JM, Russell MC, Cardona K, Staley CA 3rd, Maithel SK.

HPB (Oxford). 2014 Oct;16(10):884-91. doi: 10.1111/hpb.12276. Epub 2014 May 15.

19.

Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.

Tschuor Ch, Croome KP, Sergeant G, Cano V, Schadde E, Ardiles V, Slankamenac K, Clariá RS, de Santibaňes E, Hernandez-Alejandro R, Clavien PA.

Eur J Surg Oncol. 2013 Nov;39(11):1230-5. doi: 10.1016/j.ejso.2013.08.009. Epub 2013 Aug 29.

PMID:
23994139
20.

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S, Azoulay D, Bismuth H, Castaing D, Adam R.

J Clin Oncol. 2006 Nov 1;24(31):4983-90.

PMID:
17075116

Supplemental Content

Support Center